Which Tx Combo Is Handiest for HER2+ Breast Cancer?

The combination of trastuzumab deruxtecan (Enhertu) with pertuzumab (Perjeta) as a first-line therapy for HER2-sure evolved metastatic breast cancer has been shown to diminish the possibility for disease progression or death by bigger than the most original identical outdated-of-care therapy. Sara Tolaney, MD, MPH Sara Tolaney, MD, MPH…Learn ExtraContinue Reading

 CSCS Shareholders Approve N8.8bn Dividend

The shareholders of the Central Securities Clearing Map (CSCS) Plc non-public permitted the sum of N8.80bn as dividend payout for the 2024 financial 365 days. The approval used to be given at the thirty first Annual Customary Assembly of the firm held in Lagos. CSCS is a financial market infrastructureContinue Reading